Skip to main content
. 2023 Mar-Apr;39(2):404–408. doi: 10.12669/pjms.39.2.6365

Table-V.

Contrastive analysis of levels in T-lymphocyte subsets before and after treatment between two groups (χ̅±S) n=60.

Index Study group Control group t p
CD3+ (%) Pre-treatment 44.73±8.75 44.32±8.25 0.26 0.79
Post-treatment* 50.31±8.53 46.24±8.07 2.67 0.01
CD4+ (%) Pre-treatment 25.40±4.51 25.53±4.82 0.15 0.88
Post-treatment* 38.11±7.39 34.27±7.84 2.62 0.01
CD8+ (%) Pre-treatment 21.85±4.13 21.75±4.31 0.13 0.89
Post-treatment 22.62±5.14 22.57±5.07 0.05 0.96
CD4+/CD8+ Pre-treatment 1.38±0.41 1.35±0.52 0.35 0.73
Post-treatment* 1.96±0.51 1.46±0.27 6.71 0.00
*

p < 0.05.